Moderna and BioNTech/Pfizer both depend heavily on microfluidics, I'd call it an amazing success. All sorts of assays and genetic engineering techniques also de

Moderna and BioNTech/Pfizer both depend heavily on microfluidics, I'd call it an amazing success. All sorts of assays and genetic engineering techniques also depend on it.